IBT
MYOK

International Biotechnology Trust’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

International Biotechnology Trust’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-65,859
Closed -$8.98M – 56
2020
Q3 		$8.98M Hold
65,859
– – 2.9% 12
2020
Q2 		$6.37M Buy
65,859
+50,000
+315% +$4.17M 2.12% 18
2020
Q1 		$743K Sell
15,859
-14,141
-47% -$906K 0.34% 41
2019
Q4 		$2.19M Hold
30,000
– – 0.79% 31
2019
Q3 		$1.56M Hold
30,000
– – 0.72% 29
2019
Q2 		$1.5M Hold
30,000
– – 0.56% 43
2019
Q1 		$1.56M Buy
+30,000
New +$1.38M 0.58% 46

International Biotechnology Trust's MYOK Position: Q4 2020 in Review

International Biotechnology Trust sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 65,859 shares — an estimated $8.98M sold.

International Biotechnology Trust first reported a position in MYOK in Q1 2019 and held it in 7 quarters. The position peaked at $8.98M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • International Biotechnology Trust reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • International Biotechnology Trust sold 65,859 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $8.98M.
  • International Biotechnology Trust first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
  • International Biotechnology Trust's MyoKardia, Inc. Common Stock position peaked at $8.98M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on International Biotechnology Trust's 13F filing for Q4 2020, filed 19 Feb 2021.